Wednesday, October 14, 2020 10:43:58 AM
In the Q1 they were very cautious and explanatory about what was coming. They assured us, that there would be little or no revenue in Q2. They openly stated why. We just didn't understand what a shift in production meant.
Now, with the Q2 report, we were told point blank that volume started going out the door in July.
There was no in-depth explanation of what to expect in the next report. Then absolute silence.
The website, the document recently posted to the blog, and the article about Lugee that was just posted...do help in painting a picture of what is coming. What is coming is proof of offering. Finally and at last. A product is born.
The need to probe and question...is human nature when we are left to anticipate what is coming in the future.
Anything beyond questions and probes is opinion.
However, occasionally opinion is more than just opinion, especially when there is money on the line.
90 days is a hard slog for us to be left hanging in mid-air.
The company management knows whats at stake with this report.
Personally, I can't see them blowing this one.
In full disclosure, I have no bias against the company due to its previous management and my position in this stock is far less than 1% of the outstanding.
I'm not just an optimistic person in general, the math on this company is far too promising.
And finally, when people post unsubstantiated poison, they are either looking for attention or trying to influence the stock price.
So yeah, ignore.
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM